Joint Formulary & PAD

Spironolactone - Alopecia

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Tablets
Associated Icons :
Off Label
SPC
Restrictions / Comments :
Important

FEMALES ONLY - option for non-scarring alopecia

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Spironolactone
Indication :
Alopecia
Group Name :
Keywords :
Non-scarring alopecia.
Brand Names Include :
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Other Indications

Below are listed other indications that Spironolactone is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Alopecia.

Committee Recommendations (1)

This drug has been included on the joint formulary having been agreed by the DTC of at least one Surrey Heartlands Acute Trust.

See “Formulary Status” to identify where this drug has been agreed for use.